211 related articles for article (PubMed ID: 1583171)
21. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
[TBL] [Abstract][Full Text] [Related]
22. Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.
Barton V; Armeson K; Hampras S; Ferris LK; Visvanathan K; Rollison D; Alberg AJ
Arch Dermatol Res; 2017 May; 309(4):243-251. PubMed ID: 28285366
[TBL] [Abstract][Full Text] [Related]
23. A 5-year follow-up study of 633 cutaneous SCC excisions: Rates of local recurrence and lymph node metastasis.
Khan K; Mykula R; Kerstein R; Rabey N; Bragg T; Crick A; Heppell S; Budny P; Potter M
J Plast Reconstr Aesthet Surg; 2018 Aug; 71(8):1153-1158. PubMed ID: 29803777
[TBL] [Abstract][Full Text] [Related]
24. Seropositivity for human papillomavirus and incidence of subsequent squamous cell and basal cell carcinomas of the skin in patients with a previous nonmelanoma skin cancer.
Paradisi A; Waterboer T; Sampogna F; Tabolli S; Simoni S; Pawlita M; Abeni D
Br J Dermatol; 2011 Oct; 165(4):782-91. PubMed ID: 21561438
[TBL] [Abstract][Full Text] [Related]
25. Utilization of Topographical Mohs Micrographic Surgery Maps for Rapid Review of Clinicopathologic Characteristics of Nonmelanoma Skin Cancers of the Ear.
Tolkachjov SN
Dermatol Surg; 2018 Jan; 44(1):25-30. PubMed ID: 28858932
[TBL] [Abstract][Full Text] [Related]
26. Recurrent nonmelanoma skin cancer in southern Australia.
Czarnecki D; Staples M; Mar A; Giles G; Meehan C
Int J Dermatol; 1996 Jun; 35(6):410-2. PubMed ID: 8737875
[TBL] [Abstract][Full Text] [Related]
27. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
[TBL] [Abstract][Full Text] [Related]
28. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.
Mackenzie KA; Wells JE; Lynn KL; Simcock JW; Robinson BA; Roake JA; Currie MJ
Nephrol Dial Transplant; 2010 Jan; 25(1):300-6. PubMed ID: 19783601
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous invasive squamous cell carcinoma: 10-year experience and recommendations for follow up.
Yoong C; De'Ambrosis B
Australas J Dermatol; 2009 Nov; 50(4):261-5. PubMed ID: 19916969
[TBL] [Abstract][Full Text] [Related]
30. Surgical treatment of basal cell carcinoma and squamous cell carcinoma.
Gualdi G; Monari P; Apalla Z; Lallas A
G Ital Dermatol Venereol; 2015 Aug; 150(4):435-47. PubMed ID: 26140396
[TBL] [Abstract][Full Text] [Related]
31. Mohs Micrographic Surgery as the Standard of Care for Nail Unit Squamous Cell Carcinoma.
Gou D; Nijhawan RI; Srivastava D
Dermatol Surg; 2020 Jun; 46(6):725-732. PubMed ID: 31567588
[TBL] [Abstract][Full Text] [Related]
32. A retrospective study of squamous cell carcinoma of the nail unit diagnosed in a Belgian general hospital over a 15-year period.
Lecerf P; Richert B; Theunis A; André J
J Am Acad Dermatol; 2013 Aug; 69(2):253-61. PubMed ID: 23582571
[TBL] [Abstract][Full Text] [Related]
33. Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib.
Bhutani T; Abrouk M; Sima CS; Sadetsky N; Hou J; Caro I; Chren MM; Arron ST
J Am Acad Dermatol; 2017 Oct; 77(4):713-718. PubMed ID: 28780365
[TBL] [Abstract][Full Text] [Related]
34. Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden.
Wassberg C; Thörn M; Yuen J; Ringborg U; Hakulinen T
Int J Cancer; 1999 Feb; 80(4):511-5. PubMed ID: 9935149
[TBL] [Abstract][Full Text] [Related]
35. Non-melanoma skin cancer of the auricle is treated according to national guidelines.
Gustaitytė-Larsen D; Illum P
Dan Med J; 2013 Mar; 60(3):A4587. PubMed ID: 23484609
[TBL] [Abstract][Full Text] [Related]
36. Skin cancers in Croatia, 2003-2005: epidemiological study.
Lipozencić J; Celić D; Strnad M; Toncić RJ; Pasić A; Rados J; Znaor A
Coll Antropol; 2010 Sep; 34(3):865-9. PubMed ID: 20977074
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology and clinical evolution of non-melanoma skin cancer in renal transplant recipients: a single-center experience in São Paulo, Brazil.
Hayashida MZ; Fernandes VM; Fernandes DR; Ogawa MM; Tomimori J
Int J Dermatol; 2015 Oct; 54(10):e383-8. PubMed ID: 25969871
[TBL] [Abstract][Full Text] [Related]
38. Laboratory errors leading to nonmelanoma skin cancer recurrence after Mohs micrographic surgery.
Zabielinski M; Leithauser L; Godsey T; Gloster HM
Dermatol Surg; 2015 Aug; 41(8):913-6. PubMed ID: 26218725
[TBL] [Abstract][Full Text] [Related]
39. A 10-year prospective study of patients with skin cancer.
Czarnecki D; Sutton T; Czarnecki C; Culjak G
J Cutan Med Surg; 2002; 6(5):427-9. PubMed ID: 12196892
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection.
Rowe DE; Carroll RJ; Day CL
J Am Acad Dermatol; 1992 Jun; 26(6):976-90. PubMed ID: 1607418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
